Regulatory Publishing and Submission Services
For Life Sciences
- Home >
- Expertise
- > Regulatory Affairs Services
Streamlining Regulatory Publishing with Expertise
← Publishing Lifecycle →
New Submissions
- IND / CTA
- NDA / MAA
- ANDA
Lifecycle Submissions
- Variations
- Renewals
- SPL
Submission Planning & Management
- Document Level Publishing (DLP)
- Submission Level Publishing (SLP)
- Affiliate SuppoSubmission Dispatch / Electronic Submission (XML format)
- Archival
- Troubleshooting
Regulatory Submission Formats Supported: eCTD, NeeS, pCTD, vNeeS
Application Types:
- ANDA, NDA, BLA and IND
- MAA via CP, NP, MRP and DCP
- NDS, SNDS, ANDS, SANDS and CTA
- MAA for Generic and NCE via NP and GCC Procedure
Global Coverage:
- USA, Canada, Europe, Australia, South Africa, Gulf, China and others
Dosage Forms:
- Oral Solid Dosage Form (Tablets and Capsules)
- Parenteral (Powder for Injection, Solution and Suspension)
- Topicals (Cream, Ointments and Suppositories)
- Others (Ophthalmic, Optic and Inhaler)
Technology Based, Regulatory Intelligence Driven Global Publishing and Submission
- Solid publishing team with multi-country experience
- Centralized project management and global submission oversight
- Global delivery model for 24x7 publishing support
- Fast Turn Around, Urgent Delivery Model
- Experience with world leading publishing platforms
- Cost Effective Pricing: Unit based, Time and Material Based
- First Time Right
- Accurate publishing output
- Global Handshake supporting multiple time-zones
- Quality driven processes and procedures
- Data Security
FAQS
What are the key components of Publishing and Submission Services?
The key components of publishing for pharmaceutical application dossier submission include understanding the regulatory requirements for publishing in country of interest, identifying the right format and key components of the document, applicable format for submission (eCTD, pCTD, NeeS etc), submission gateways (ESG etc), suitable publishing software, submission planning and trackers, quality check at each level of document and submission level publishing, submission to health authority and archiving.
How do you support Publishing and Submission in multiple countries?
Our centralized publishing and submission team has experience in publishing dossier in multiple formats, products and dosages forms across multiple countries worldwide. We have established processes and procedures to ensure high quality, right first time publishing submissions based on our experience and quality driven systems and KPIs.
What are the key challenges faced by Pharmaceutical companies during Publishing?
The key challenges faced by pharmaceutical and biotech companies during publishing include, understanding of country specific publishing requirements and guidelines, lack of established processes, lack of experienced in house team for publishing, availability of cost effective software for publishing, shorter deadlines and time sensitive multiple submission requirements, experience in multi-country experience, among other challenges.
How do you stay updated with changing regulations in international countries related to Publishing and Submissions?
Pharma Wizard’s centralized regulatory intelligence team, supported by structured processes and a robust technology platform, continuously tracks new regulations, guidelines, notifications, and updates from global health authorities. Our regional teams also contribute insights through their strong networks with local trade and industry associations. All information is processed, structured, and stored in a central repository—providing actionable intelligence that supports efficient and compliant publishing and submission activities.
Still Have Questions ?
Specialized Regulatory Affairs Services Across Multiple Industries
Pharmaceuticals
MedTech
Cosmetics
Nutrition
Biologics
Veterinary
Expert Regulatory Services To Streamline Compliance
- Regulatory Intelligence & Strategy
- Medical & Technical Writing
- Publishing & Submission
- Product Registration
- Investigation New Drug Application (IND)
- New Drug Application (NDA)
- Post Approval Lifecycle Maintenance
- Artwork and Label Review
- Ad Promo Review






















